3-[2-Fluoro-3-[3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropyl]phenyl]-2-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid | 887970-07-2

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮
• 英文名称: 3-[2-Fluoro-3-[3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropyl]phenyl]-2-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid
• CAS: 887970-07-2
• 化学式: C₂₉H₃₉FN₂O₆
• 分子量: 530.637
• InChiKey: WFXLVNCSKKYMIH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  38
• 可旋转键数：
  13
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.48
• 拓扑面积：
  114
• 氢给体数：
  3
• 氢受体数：
  7

文献信息

• Macrocyclic Tertiary Amine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
  申请人：Nantermet Philippe G.

  公开号：US20080269302A1

  公开（公告）日：2008-10-30

  The present invention is directed to macrocyclic tertiary amine compounds represented by general formula (I) which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

  本发明涉及由通式(I)表示的大环三级胺化合物，它们是β-分泌酶酶的抑制剂，并且在治疗β-分泌酶酶参与的疾病，如阿尔茨海默病方面具有用途。本发明还涉及包含这些化合物的制药组合物，以及在治疗β-分泌酶酶参与的这些疾病方面使用这些化合物和组合物。
• US7678783B2
  申请人：——

  公开号：US7678783B2

  公开（公告）日：2010-03-16